You may have heard about — or maybe even experienced — the short-term side effects of Ozempic® — such as nausea, vomiting, ...

The researchers analysed 4,000 obese participants aged 12 to 19 on semaglutide, the drug in Ozempic and Wegovy, or liraglutide, sold as Victoza and ... trend continued after a three year follow ...

Specifically, the CWR team looked at three years of healthcare data for folks who had just begun taking diabetes drugs like insulin, Ozempic, and the GLP-1 drug liraglutide that's sold under the brand ...

Telehealth company Hims & Hers said late Monday in an earnings update that it plans to launch a generic version of Novo ...

Victoza, and others to just once every four months. A drug candidate, based on pioneering UCL and Moorfields Eye Hospital research and currently under development by SIFI S.p.A., has been found to ...

Ozempic, Wegovy or Mounjaro: the battle of the weight-loss injections - As weight-loss injections emerge as key players in ...

When you're taking GLP-1 medications for weight loss, it's easy for nutrition to get overlooked because while semaglutide ...

Whoever wins the presidency, the 2024 election has outsized implications for California. The elevation of Democratic Vice President Kamala Harris to the highest office in the land would make her the ...

Liraglutide’s original formulation, designed to treat type 2 diabetes, was marketed as Victoza. Its ability to cause weight loss was evident soon after it entered the market. Shortly after ...

A review of the medical records of thousands of adolescents treated for obesity found that kids who received the GLP-1 medications semaglutide or liraglutide were less likely to ...

A 2021 clinical trial found that participants taking semaglutide lost an average of 14.9 percent of their body weight after ...

Ozempic's popularity has been on the rise and it has impacted a number of stock sectors. Click to read this article where we look to discover which stocks benefit.